Psychedelic-Assisted Therapy: Breakthrough for Whom?
Psychiatr Serv April 1, 2026
The article critically examines the claims of a breakthrough in psychedelic-assisted therapy, questioning who benefits from these treatments. It argues that the evidence, while promising, is not universally applicable and may primarily serve certain populations, potentially overlooking broader systemic and accessibility issues. The piece calls for a more nuanced understanding of the therapy's efficacy and equity.